PEPFAR Country/Regional Operational Plans (COPs/ROPs) Database, amfAR, The Foundation for AIDS Research

Home
About
Countries/Regions
- Countries/Regions
  
  PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
  Select a Country or Region
Partners
- Allocations
  
  Partners
  
  PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
  Select a Partner View Full List
  
  Organizational Types
  
  Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
  Select Organizational Type View Full List
Program Areas
- Allocations
  
  Program Areas
  
  Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
  Select an Area View Full List
  Budget Codes
  
  Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
  Select a Budget Code View Full List
  
  Expenditures
  
  Program Areas
  
  Expenditure Program Areas track general areas of PEPFAR expenditure.
  Select an Area
  Sub-Program Areas
  
  Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
  Select a Sub-Area
  Object Classes
  
  Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
  Select an Object Class
Cross-Cutting & Populations
- Allocations
  
  Cross-Cutting & Populations
  
  Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
  Select Cross-cutting Attributes View Full List
  
  Expenditures
  
  Beneficiaries
  
  Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
  Select a Population
  Sub-Beneficiaries
  
  Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
  Select a Population
Targets
- Targets
  
  PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
  Select an Indicator
Advanced Selection

Budget Codes	Budget Code Description	Amount	Percentage
OHSS	Health Systems Strengthening	$16,770,514	27.93%
HVCT	Testing: HIV Testing and Counseling	$7,723,240	12.86%
HVOP	Sexual Prevention: Other Sexual Prevention	$6,768,813	11.27%
HBHC	Care: Adult Care and Support	$6,148,074	10.24%
HTXS	Treatment: Adult Treatment	$5,285,953	8.80%
MTCT	Biomedical Prevention: Prevention of Mother to Child Transmission	$4,569,378	7.61%
HVSI	Strategic Information	$4,467,494	7.44%
HVAB	Sexual Prevention: Abstinence/Be Faithful	$3,848,203	6.41%
CIRC	Biomedical Prevention: Voluntary Medical Male Circumcision	$1,262,167	2.10%
HKID	Care: Orphans and Vulnerable Children	$855,558	1.42%
HLAB	Laboratory Infrastructure	$821,432	1.37%
PDCS	Care: Pediatric Care and Support	$717,089	1.19%
HMBL	Biomedical Prevention: Blood Safety	$369,891	0.62%
PDTX	Treatment: Pediatric Treatment	$272,718	0.45%
HVTB	Care: TB/HIV	$175,000	0.29%
HMIN	Biomedical Prevention: Injection Safety	$0	0.00%
IDUP	Prevention: Injecting and Non-Injecting Drug Use	$0	0.00%
HTXD	Treatment: ARV Drugs	$0	0.00%

Year	Mechanism ID	Amount
2007	1	$6,676,087
2008	8256	$505,869
2008	7860	$3,895,131
2009	1	$5,802,000
2010	12471	$0
2010	12472	$0
2010	1	$3,390,000
2011	13018	$0
2011	13132	$0
2011	13142	$0
2011	13208	$0
2011	13283	$0
2011	13324	$0
2011	13429	$0
2011	1	$3,025,000
2012	1	$3,217,187
2013	16868	$0
2013	16931	$0
2013	17118	$0
2013	1	$929,565
2014	17716	$0
2014	17714	$0
2014	17713	$0
2014	17708	$0
2014	17700	$0
2014	17675	$0
2014	1	$4,900,000
2015	17805	$0
2015	1	$412,178
2016	18397	$0
2016	1	$800,000
2018	70312	$0
2018	70313	$0
2018	70314	$0
2018	70315	$0
2018	70316	$0
2018	70317	$0
2018	70318	$0
2018	70319	$0
2018	70320	$0
2018	70515	$0
2018	1	$1,298,377
2019	1	$401,924
2019	1	$15,000,000
2020	1	$2,493,561
2020	1	$7,283,645

Total Allocations: $60,030,524

Partner Contract Information